Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 12, 2010, Pages 8482-8490

  Yang, Raymond S H ^a,b   Chang, Louis W ^b   Yang, Chung Shi ^b   Lin, Pinpin ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

PBPK modeling; Pharmacokinetics; Physiologically based pharmacokinetics

Indexed keywords

ANTICANCER DRUG; CANCER CHEMOTHERAPY; COMMERCIAL PRODUCTS; COMPUTATIONAL TECHNOLOGY; COMPUTER MODELING; CONTROL RELEASE; CONTROLLED RELEASE; DEFENSE SYSTEM; DELIVERY VEHICLE; DRUG COMBINATIONS; DRUG EFFECTS; ENVIRONMENTAL FATE; GENETIC MATERIALS; HEALTH EFFECTS; IMMUNOTOXINS; MEDICAL SCIENCE; MULTIDRUG RESISTANCE; NANOTOXICOLOGY; PBPK MODELING; PHARMACOKINETIC MODELING; PHARMACOKINETICS AND PHARMACODYNAMICS; PHYSICOCHEMICAL PROPERTY; PHYSIOLOGICALLY-BASED PHARMACOKINETICS; POTENTIAL HEALTH; TUMOR BIOLOGY;

CHEMICAL PROPERTIES; CHEMOTHERAPY; MAMMALS; MEDICAL IMAGING; MEDICINE; PHARMACOKINETICS; PHYSIOLOGY; TISSUE; TOXICITY;

NANOPARTICLES;

NANOPARTICLE;

ANIMAL; BIOLOGICAL MODEL; DRUG DELIVERY SYSTEM; HUMAN; PHARMACOKINETICS; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MODELS, BIOLOGICAL; NANOPARTICLES; PHARMACOKINETICS;

EID: 79952108787     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2687     Document Type: Conference Paper

References (34)

1. R. Hardman, Environ. Health Perspect. 114, 165 (2006).
2. Royal commission on environmental pollution, Novel Materials in the Environment: The Case of Nanotechnology (2008), p. 147, http://www.rcep.org.uk/ reports/27-novel%20materials/27-novelmaterials.htm.
3. A. D. Maynard, R. J. Aitken, T. Butz, V. Colvin, K. Donaldson, G. Oberdorster, M. A. Philbert, J. Ryan, A. Seaton, V. Stone, S. S. Tinkle, L. Tran, N. J. Walker, and D. B. Warheit, Nature 444, 267 (2006).
4. http://www.nano.gov/html/facts/home-facts.html, November 10, (2008).
5. Y. S. Kim, J. S. Kim, H. S. Cho, D. S. Rha, J. M. Kim, J. D. Park, B. S. Choi, R. Lim, H. K. Chang, Y. H. Chung, I. H. Kwon, J. Jeong, B. S. Han, and I. J. Yu, Inhal. Toxicol. 20, 575 (2008).
6. S. D. Li and L. Huang, Mol Pharm. 5, 496 (2008).
7. E. M. Allen, W. W. K. Cheng, J. I. Hare, and K. M. Laginha, Anti-Cancer Agents in Medicinal Chemistry 6, 513 (2006).
8. P. R. Lockman, J. M. Koziara, R. J. Mumper, and D. D. Allen, J. Drug Target. 12, 635 (2004).
9. I. P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar, J. Control Release 127, 97 (2008).
10. J. Kreuter, P. Ramge, V. Petrov, S. Hamm, S. E. Gelperina, B. Engelhardt, R. Alyautdin, H. von Briesen, and D. J. Begley, Pharm Res. 20, 409 (2003).
11. A. C. Amrite, H. F. Edelhauser, S. R. Singh, and U. B. Kompella, Mol. Vis. 14, 150 (2008).
12. N. Amirshahi, R. N. Alyautdin, S. Sarkar, S. M. Rezayat, M. A. Orlova, I. V. Trushkov, A. L. Buchachenko, and D. A. Kuznetsov, Arch. Med. Res. 39, 549 (2008).
13. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, and Z. Zhang, Int. J. Pharm. 356, 333 (2008).
14. K. Cho, X. Wang, S. Nie, Z. G. Chen, and D. M. Shin, Clin. Cancer Res. 14, 1310 (2008).
15. A. Wang and S. Li, BMC Biotechnol. 8, 46 (2008).
16. M. Breunig, S. Bauer, and A. Goepferich, Eur. J. Pharm Biopharm. 68, 112 (2008).
17. D. W. Nyman, K. J. Campbell, E. Hersh, K. Long, K. Richardson, V. Trieu, N. Desai, M. J. Hawkins, and D. D. Von Hoff, J. Clin. Oncol. 23, 7785 (2005).
18. C. E. Soma, C. Dubernet, D. Bentolila, S. Benita, and P. Couvreur, Biomater. 21, 1 (2000).
19. S. M. Moghimi and A. C. Hunter, Crit. Rev. Therapeu. Drug Carrier Syst. 18, 527 (2001).
20. M. E. Akerman, W. C. Chan, P. Laakkonen, S. N. Bhatia, and E. Ruoslahti, Proc. Natl. Acad. Sci. USA 99, 12617 (2002).
21. D. R. Larson, W. R. Zipfel, R. M. Williams, S. W. Clark, M. P. Bruchez, F. W Wise, and W. W. Webb, Science 300, 1434 (2003).
22. Y T. Lim, S. Kim, A. Nakayama, N. E. Stott, M. G. Bawendi, and J. V. Frangioni, Mol. Imaging 2, 50 (2003).
23. N. y Morgan, S. English, W. Chen, V. Chernomordik, A. Russo, P. D. Smith, and A. Gandjbakhche, Acad. Radiol. 12, 313 (2005).
24. H. L. Ma, Y F. Xu, X. R. Qi, Y. Maitani, and T. Nagai, Int. J. Pharm. 354, 217 (2008).
25. A. E. Porter, M. Gass, K. Muller, J. N. Skepper, P. A. Midgley, and M. Welland, Nat. Nanotechnol. 2, 713 (2007).
26. A. de la Zerda, C. Zavaleta, S. Keren, S. Vaithilingam, S. Bodapati, Z. Liu, J. Levi, B. R. Smith, T. J. Ma, O. Oralkan, Z. Cheng, X. Chen, H. Dai, B. T. Khuri-Yakub, and S. S. Gambhir, Nat. Nanotechnol. 3, 557 (2008).
27. A. Al Faraj, K. Cieslar, G. Lacroix, S. Gaillard, E. Canet-Soulas, and Y Crémillieux, Nano Lett. 9, 1023 (2009).
28. M. S. Fallon, M. Varshney, D. M. Dennis, and A. Chauhan, J. Pharmacokinet. Pharmacodyn. 31, 381 (2004).
29. E. y Ng, W. K. Ng, and S. S. Chiam, J. Med. Syst. 32, 85 (2008).
30. R. Venkatasubramanian, M. A. Henson, and N. S. Forbes, J. Theor. Biol. 253, 98 (2008).
31. P. P. Lin, J. W. Chen, L. W. Chang, J. P. Wu, L. Redding, H. Chang, T. K. Yeh, C. S. Yang, M. H. Tsai, H. J. Wang, Y C. Kuo, and R. S. H. Yang, Environ. Sci. Technol. 42, 6264 (2008).
32. M. B. Reddy, R. S. H. Yang, H. J. Clewell, III, and M. E. Andersen, Physiologically Based Pharmacokinetics: Science and Applications, John Wiley and Sons, Hoboken, New Jersey (2005), p. 420.
33. H. van de Waterbeemd and E. Gifford, Nat. Rev. Drug Discov. 2, 192 (2003).
34. R. S. H. Yang, L. W. Chang, J. P. Wu, M. H. Tsai, H. J. Wang, Y C. Kuo, T. K. Yeh, C. S. Yang, and P. P. Lin, Environ. Health Perspect. 115, 1339 (2007).